Efficacy of Oral Zinc Acetate in Reducing Hyperbilirubinemia in Full-Term and Near-Term High Risk Neonates

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 17, Issue 2

Abstract

Objective: To determine the efficacy of oral zinc supplementation in reducing incidence of hyperbilirubinemia and level of serum total bilirubin (STB) during the first week of life in full-term and near-term high risk neonates in comparison with placebo. Method: We conducted a randomized double-blind placebo-controlled trial on 100 neonates born at ≥35 weeks of gestation with STB ≥5 mg/dl at 24 ± 6 hours of age. They were administered either 10 mg zinc acetate syrup (zinc group) or placebo (control group) in twice daily doses till day 7 of life. Incidence of hyperbilirubinemia (STB ≥15 mg/dl) anytime between day 2 to 7 of life and mean STB levels on day 7 of age were compared between the two groups. Results: Incidence of hyperbilirubinemia was significantly lower in the zinc group (8%) as compared to placebo group (26%); p= 0.033. Mean STB level on day 7 of life was significantly lower in the zinc group (7.828±3.36 mg/dl) as compared to placebo group (9.474±3.1mg/dl); p= 0.017. No significant adverse effects related to oral zinc administration were noted. Conclusion: Oral zinc in a dose of 10 mg/day reduces the incidence of hyperbilirubinemia and mean STB levels in the first week of life in at-risk full-term and near-term neonates.

Authors and Affiliations

Dr. Karnika Agrawal, Dr. Surendra Kumar, Dr. R. S. Sethi3

Keywords

Related Articles

Mandibular First Molar with a Radix Entomolaris: A Case Report

Complete disinfection of the root canal system is of utmost importance to achieve a successful root canal treatment, the main objective is the elimination of the bacteria from the infected root canals.RadixEntomolaris is...

Life Style Associated Risk Factors for Overweight and Obesity in Adolescent Age Group 15 – 18 Years in Karaikal Region

Objectives: To find out the various life style associated risk factors for overweight and obesity among adolescents between 15 – 18 years in karaikal region. Methods: A Cross sectional study was carried out in the age gr...

Comparative Study To Evaluate The Effect Of Zolendronic Acid And Teriparatide On Bone Mineral Density In The Treatment Of Osteoporosis

Background: Osteoporosis is a systemic metabolic bone disease which is characterized by low bone mass and deterioration of bone micro-architecture, resulting in increased susceptibility to fractures. The pathological fra...

Update of Transfusion Transmitted Infections among Donors of North Coastal Andhra

Background: Blood transfusion service (BTS) is an integral and indispensable part of the healthcare system. Safe blood availability is very important to prevent transfusion transmitted infections (TTI). Highly sensitive...

Proton pump inhibitors may improve glycemic control in patients with Type 2 DM- A prospective cohort study

The study objectives were to determine the effect of proton pump inhibitors on glycemic control in patients with Type 2 DM by measuring the parameters like FBS, PPBS and HbA1C. A Prospective Cohort study was conducted in...

Download PDF file
  • EP ID EP362993
  • DOI 10.9790/0853-1702092731
  • Views 83
  • Downloads 0

How To Cite

Dr. Karnika Agrawal, Dr. Surendra Kumar, Dr. R. S. Sethi3 (2017). Efficacy of Oral Zinc Acetate in Reducing Hyperbilirubinemia in Full-Term and Near-Term High Risk Neonates. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 17(2), 27-31. https://europub.co.uk/articles/-A-362993